Trials / Completed
CompletedNCT00047476
D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients
Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of d-MPH in the Treatment of Fatigue and Neurobehavioral Impairment Related to Chemotherapy in Adult Cancer Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- Celgene Corporation · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexmethylphenidate(d-mph) |
Timeline
- Start date
- 2002-06-01
- Completion
- 2004-03-01
- First posted
- 2002-10-09
- Last updated
- 2005-06-24
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00047476. Inclusion in this directory is not an endorsement.